These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18064438)

  • 1. Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.
    Armstrong SR; Briones S; Horger B; Richardson CL; Jaw-Tsai S; Hegde SS
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):341-9. PubMed ID: 18064438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacodynamic assays for M2 and M3 muscarinic receptors.
    Armstrong S; Steinfeld T; Pulido-Rios MT; Hegde SS
    Curr Protoc Pharmacol; 2010 Mar; Chapter 12():Unit 12.13. PubMed ID: 22294364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of bladder muscarinic receptor subtypes by experimental pathologies.
    Ruggieri MR; Braverman AS
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):311-25. PubMed ID: 16879497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors in the bladder: from basic research to therapeutics.
    Hegde SS
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
    Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
    Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder.
    Braverman AS; Tibb AS; Ruggieri MR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):869-74. PubMed ID: 16243961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
    Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model.
    Trifilieff A; Ethell BT; Sykes DA; Watson KJ; Collingwood S; Charlton SJ; Kent TC
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):9-16. PubMed ID: 26026369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle.
    Kitazawa T; Hirama R; Masunaga K; Nakamura T; Asakawa K; Cao J; Teraoka H; Unno T; Komori S; Yamada M; Wess J; Taneike T
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):503-13. PubMed ID: 18071676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subtypes of muscarinic receptors for neurogenic bladder contraction in rats.
    Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Nishikibe M; Noguchi K
    Eur J Pharmacol; 2002 Oct; 452(2):245-53. PubMed ID: 12354576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolterodine--a new bladder-selective antimuscarinic agent.
    Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
    Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder.
    Braverman AS; Doumanian LR; Ruggieri MR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):875-80. PubMed ID: 16243962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
    Ohtake A; Saitoh C; Yuyama H; Ukai M; Okutsu H; Noguchi Y; Hatanaka T; Suzuki M; Sato S; Sasamata M; Miyata K
    Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment.
    Maruyama S; Tsukada H; Nishiyama S; Kakiuchi T; Fukumoto D; Oku N; Yamada S
    J Pharmacol Exp Ther; 2008 Jun; 325(3):774-81. PubMed ID: 18326811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.
    Schneider T; Hein P; Michel-Reher MB; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):71-8. PubMed ID: 16059734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
    Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.